JPMorgan Appoints Sri Kosaraju as Global Chair of Healthcare Investment Banking
JPMorgan Chase has appointed Sri Kosaraju as the global chair of investment banking for its healthcare industry vertical. This strategic move aims to bolster its competitive edge in healthcare M&A amid robust dealmaking activity expected to continue through 2026.
洞察:
JPMorgan Chase & Co. announced the appointment of Sri Kosaraju sri kosaraju as the global chair of investment banking for its healthcare industry vertical on January 7, 2026. This key appointment comes as the firm continues to strengthen its competitive position in healthcare mergers and acquisitions (M&A), with dealmaking activity anticipated to remain robust throughout the year.
Kosaraju, who will be based in San Francisco, brings a wealth of experience to the role. He previously served as CEO of Inscripta and has a deep history with JPMorgan, having spent 16 years at the firm where he played a pivotal role in building its healthcare franchise. In his new position, Kosaraju will report to Filippo Gori filippo goriand John Simmons john simmons, co-heads of global banking.
